{"id":1696,"date":"2020-12-16T11:16:18","date_gmt":"2020-12-16T02:16:18","guid":{"rendered":"https:\/\/clarivate.com\/jp\/blog\/%e3%82%aa%e3%83%b3%e3%83%87%e3%83%9e%e3%83%b3%e3%83%89webinar%e3%81%ae%e3%81%94%e7%b4%b9%e4%bb%8b\/?lang=ja"},"modified":"2020-12-16T11:16:18","modified_gmt":"2020-12-16T02:16:18","slug":"on-demand-webinar-ls","status":"publish","type":"post","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/ja\/blog\/on-demand-webinar-ls\/","title":{"rendered":"\u30aa\u30f3\u30c7\u30de\u30f3\u30c9Webinar\u306e\u3054\u7d39\u4ecb"},"content":{"rendered":"

\u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u304c\u5b9f\u65bd\u3057\u3066\u3044\u308b\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u95a2\u4fc2\u306eWebinar\u30aa\u30f3\u30c7\u30de\u30f3\u30c9\u9332\u753b\u3092\u307e\u3068\u3081\u3066\u3054\u7d39\u4ecb\u3057\u3066\u304a\u308a\u307e\u3059\u3002
\n\u3054\u90fd\u5408\u306b\u5408\u308f\u305b\u3066\u3044\u3064\u3067\u3082\u8996\u8074\u53ef\u80fd\u306aWebinar\u30b7\u30ea\u30fc\u30ba\u3092\u662f\u975e\u3054\u53c2\u8003\u304f\u3060\u3055\u3044\u3002<\/p>\n

\uff08\u6ce8\uff1a\u8b1b\u6f14\u8a00\u8a9e\u306f\u5168\u3066\u82f1\u8a9e\u3068\u306a\u308a\u307e\u3059\u3002\uff09<\/p>\n

 <\/p>\n

Digital innovation in clinical trials: Key questions answered<\/a>
\n\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\uff1a\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u30c7\u30b8\u30bf\u30eb\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u304b\u3089\u629c\u7c8b\u3057\u305f\u30b7\u30e7\u30fc\u30c8\u30e0\u30fc\u30d3\u30fc
\n(2020\u5e749\u670822\u65e5)<\/p>\n

 <\/p>\n

Digital innovation in clinical trials<\/a>
\n\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\uff1a\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u30c7\u30b8\u30bf\u30eb\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3
\n(2020\u5e749\u670822\u65e5)<\/p>\n

 <\/p>\n

Deep-dives into generics and API manufacturing industry: Focus on China, India, and biosimilars<\/a>
\n\u2022 \u898b\u76f4\u3055\u308c\u308b\u4e2d\u56fd\u306e\u30b8\u30a7\u30cd\u30ea\u30c3\u30af\u533b\u85ac\u54c1\u696d\u754c
\n\u2022 \u9032\u5316\u3059\u308b\u30d0\u30a4\u30aa\u30b7\u30df\u30e9\u30fc
\n\u2022 \u30a4\u30f3\u30c9\u306e\u30b8\u30a7\u30cd\u30ea\u30c3\u30af\u533b\u85ac\u54c1\u3068API\u696d\u754c
\n(2020\u5e7411\u6708)<\/p>\n

 <\/p>\n

Trends in global API manufacturing<\/a>
\n\u3053\u306e\u30a6\u30a7\u30d3\u30ca\u30fc\u3067\u306f\u3001\u5f53\u793e\u306e\u696d\u754c\u304a\u3088\u3073\u30c7\u30fc\u30bf\u306e\u5c02\u9580\u5bb6\u304c\u4e16\u754c\u306eAPI\u696d\u754c\u306e\u6982\u8981\u3084COVID-19\u304c\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u3084API\u88fd\u9020\u696d\u754c\u306b\u4e0e\u3048\u305f\u5f71\u97ff\u306a\u3069\u3092\u7d39\u4ecb\u3057\u307e\u3059\u3002
\n(2020\u5e7411\u67084\u65e5)<\/p>\n

 <\/p>\n

The future of precision medicine<\/a>
\n\u904e\u53bb\u306e\u500b\u5225\u5316\u533b\u7642\u306b\u95a2\u3059\u308b\u81e8\u5e8a\u533b\u7642\u8a66\u9a13\u304b\u3089\u5f97\u3089\u308c\u305f\u3001\u816b\u760d\u5b66\u306b\u304a\u3051\u308b\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u306e\u6b74\u53f2\u3084\u975e\u304c\u3093\u95a2\u9023\u75be\u60a3\u306b\u304a\u3051\u308b\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u4f7f\u7528\u306e\u9032\u5316\u306a\u3069\u3092\u7d39\u4ecb\u3057\u307e\u3059\u3002
\n(2020\u5e7410\u670814\u65e5\uff09<\/p>\n

 <\/p>\n

Trends in university-pharma partnerships<\/a>
\n\u5f53\u793e\u306e\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u5206\u91ce\u306e\u5c02\u9580\u5bb6\u304c\u3001\u5b66\u8853\u6a5f\u95a2\u3068\u88fd\u85ac\u4f1a\u793e\u306e\u9593\u306e\u63d0\u643a\u6d3b\u52d5\u3092\u3088\u308a\u6df1\u304f\u6398\u308a\u4e0b\u3052\u3001\u5b66\u8853\u7814\u7a76\u3092\u88fd\u85ac\u696d\u754c\u306e\u30cb\u30fc\u30ba\u306b\u5408\u308f\u305b\u308b\u305f\u3081\u306e\u30d9\u30b9\u30c8\u30d7\u30e9\u30af\u30c6\u30a3\u30b9\u30fb\u30a2\u30d7\u30ed\u30fc\u30c1\u3067\u6700\u5927\u306e\u30a4\u30f3\u30d1\u30af\u30c8\u3092\u5f97\u308b\u65b9\u6cd5\u306a\u3069\u3092\u7d39\u4ecb\u3057\u307e\u3059\u3002
\n(2020\u5e749\u670829\u65e5)<\/p>\n

 <\/p>\n

Building a robust pharma generics product portfolio<\/a>
\nBiophore\u793e\u3068IQGEN-X\u793e\u306e\u696d\u754c\u30ea\u30fc\u30c0\u30fc\u304c\u4e00\u5802\u306b\u4f1a\u3057\u3001\u88fd\u85ac\u696d\u754c\u306b\u304a\u3051\u308b\u8d77\u696d\u5bb6\u7cbe\u795e\u3001\u5f7c\u3089\u304c\u76f4\u9762\u3057\u3066\u3044\u308b\u8ab2\u984c\u3001\u305d\u3057\u3066\u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u304c\u30a4\u30f3\u30b5\u30a4\u30c8\u306b\u5bcc\u3093\u3060\u30a4\u30f3\u30c6\u30ea\u30b8\u30a7\u30f3\u30b9\u3092\u63d0\u4f9b\u3059\u308b\u3053\u3068\u3067\u3001\u5f7c\u3089\u3068\u30d1\u30fc\u30c8\u30ca\u30fc\u3092\u7d44\u3080\u4e0a\u3067\u3069\u306e\u3088\u3046\u306b\u91cd\u8981\u306a\u5f79\u5272\u3092\u679c\u305f\u3057\u3066\u304d\u305f\u304b\u3092\u7d39\u4ecb\u3057\u307e\u3059\u3002
\n(2020\u5e747\u670823\u65e5)<\/p>\n

 <\/p>\n

Trends in clinical trial planning<\/a>
\n\u30d7\u30ed\u30c8\u30b3\u30eb\u3001\u30b5\u30a4\u30c8\u306e\u8b58\u5225\u3001\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u306e\u9078\u629e\u306a\u3069\u3001\u904e\u53bb10\u5e74\u9593\u306e\u6570\u4e07\u306e\u8a66\u9a13\u30c7\u30b6\u30a4\u30f3\u304b\u3089\u898b\u3048\u308b\u3001\u81e8\u5e8a\u8a66\u9a13\u3092\u521d\u65e5\u304b\u3089\u6210\u529f\u3055\u305b\u308b\u305f\u3081\u306e\u30dd\u30a4\u30f3\u30c8
\n\uff082020\u5e747\u670815\u65e5\uff09<\/p>\n

 <\/p>\n

Winning in global regulatory with AI<\/a>
\nAI\u3092\u6d3b\u7528\u3057\u305f\u30b0\u30ed\u30fc\u30d0\u30eb\u898f\u5236\u3078\u306e\u5bfe\u5fdc
\n\uff082020\u5e746\u67083\u65e5\uff09<\/p>\n

 <\/p>\n

New target identification and validation<\/a>
\n\u65b0\u3057\u3044\u30bf\u30fc\u30b2\u30c3\u30c8\u306e\u540c\u5b9a\u3068\u691c\u8a3c\u306b\u95a2\u3059\u308b\u6700\u65b0\u77e5\u898b
\n\uff082020\u5e745\u6708\uff09<\/p>\n

 <\/p>\n

Coupling artificial intelligence and network biology: Generate insights for disease understanding and target identification<\/a>
\nAI\u304c\u3069\u306e\u3088\u3046\u306b\u751f\u7269\u5b66\u7684\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u7814\u7a76\u3092\u5909\u3048\u308b\u306e\u304b
\n\uff082020\u5e746\u67083\u65e5\uff09<\/p>\n

 <\/p>\n

Navigating the COVID-19 landscape: Managing through today\u2019s (even more) dynamic R&D environment<\/a>
\nCOVID-19\u3092\u53d6\u308a\u5dfb\u304f\u7814\u7a76\u958b\u767a\u74b0\u5883
\n\uff082020\u5e745\u6708\uff09<\/p>\n

 <\/p>\n

Simplifying global complexity: The role of AI from licensing to regulatory compliance<\/a>
\n\u30e9\u30a4\u30bb\u30f3\u30b9\u304b\u3089\u898f\u5236\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u306b\u304a\u3088\u3076AI\u306b\u3088\u308b\u52b9\u7387\u5316\u306e\u5b9f\u4f8b\u3092\u3054\u7d39\u4ecb
\n\uff082020\u5e744\u6708\uff09<\/p>\n

 <\/p>\n

Enhancing drug safety: Practical applications of artificial intelligence in toxicology<\/a>
\n\u4eba\u5de5\u77e5\u80fd\u3092\u85ac\u7269\u306e\u5b89\u5168\u6027\u3092\u9ad8\u3081\u308b\u305f\u3081\u306b\u5fdc\u7528\u3059\u308b\u5b9f\u4f8b\u306b\u3064\u3044\u3066\u3054\u7d39\u4ecb<\/p>\n

 <\/p>\n

Pharma deal-making trends in digital health<\/a>
\n\u30c7\u30b8\u30bf\u30eb\u30d8\u30eb\u30b9\u306b\u95a2\u3059\u308b\u6700\u65b0\u306e\u30c7\u30a3\u30fc\u30eb\u30c8\u30ec\u30f3\u30c9\u3092\u3054\u7d39\u4ecb
\n\uff082020\u5e743\u670817\u65e5\uff09<\/p>\n

 <\/p>\n

Outlook 2020: Best practices for regulatory success<\/a>
\n2020\u5e74\u306e\u898f\u5236\u3078\u306e\u5bfe\u5fdc\u3092\u9032\u3081\u308b\u305f\u3081\u30012019\u5e74\u306e\u898f\u5236\u72b6\u6cc1\u3092\u632f\u308a\u8fd4\u308a\u307e\u3059
\n\uff082020\u5e743\u67085\u65e5\uff09<\/p>\n

 <\/p>\n

Outlook 2020: Regulatory trends and challenges<\/a>
\n2020\u5e74\u306b\u4e88\u60f3\u3055\u308c\u308b\u6700\u65b0\u306e\u898f\u5236\u52d5\u5411: \u30d0\u30c3\u30c1\u751f\u7523\u304b\u3089\u9023\u7d9a\u751f\u7523\u3078 ~ \u30c8\u30ec\u30f3\u30c9\u3068\u8ab2\u984c ~
\n\uff082020\u5e741\u670829\u65e5\uff09<\/p>\n

 <\/p>\n

Horizon 2020: 2019 global regulatory trends and outlook<\/a>
\n2019\u5e74\u306e\u898f\u5236\u52d5\u5411\u3068\u4eca\u5f8c\u306e\u5c55\u671b: \u5e0c\u5c11\u75be\u60a3\u3084\u533b\u85ac\u54c1\u95a2\u9023\u6280\u8853\u306e\u9032\u6b69\u306b\u5bfe\u5fdc\u3057\u305f\u898f\u5236\u30e9\u30f3\u30c9\u30b9\u30b1\u30fc\u30d7\u306e\u5909\u5316
\n\uff082019\u5e7411\u670812\u65e5\uff09<\/p>\n

 <\/p>\n

How to build a profitable generic pipeline before your competition<\/a>
\n\u30b8\u30a7\u30cd\u30ea\u30c3\u30af\u533b\u85ac\u54c1\u306e\u6b21\u4e16\u4ee3\u30ea\u30fc\u30c0\u30fc\u306e\u7279\u6027\u3001\u5730\u57df\u3001\u88fd\u54c1\u30af\u30e9\u30b9\u306b\u95a2\u3059\u308b\u8a73\u7d30\u306a\u5206\u6790
\n\uff082019\u5e7411\u670820\u65e5\uff09<\/p>\n

 <\/p>\n

Choosing the right drug target<\/a>
\n\u9069\u5207\u306a\u5275\u85ac\u30bf\u30fc\u30b2\u30c3\u30c8\u306e\u9078\u629e\u3068\u306f\uff1f\uff1a\u5f8c\u671f\u6bb5\u968e\u306e\u5931\u6557\u3092\u56de\u907f\u3057\u3001\u6210\u529f\u306e\u53ef\u80fd\u6027\u3092\u9ad8\u3081\u308b\u65b9\u6cd5
\n\uff082019\u5e7411\u670812\u65e5\uff09<\/p>\n

 <\/p>\n

Simplifying global complexity: The role of AI from licensing to regulatory compliance<\/a>
\nAI\u3092\u6d3b\u7528\u3057\u305f\u85ac\u7269\u30e9\u30a4\u30d5\u30b5\u30a4\u30af\u30eb\u306b\u9769\u65b0\u3092\u3082\u305f\u3089\u3059\u65b9\u6cd5\u3092\u3054\u7d39\u4ecb\u3057\u307e\u3059\u3002
\n\uff082019\u5e7410\u670829\u65e5\uff09<\/p>\n

 <\/p>\n

Managing global regulatory complexity<\/a>
\n\u30b0\u30ed\u30fc\u30d0\u30eb\u306b\u304a\u3051\u308b\u8907\u96d1\u306a\u898f\u5236\u3092\u3069\u306e\u3088\u3046\u306b\u7ba1\u7406\u3059\u308b\u304b\uff1f\uff1a\u81e8\u5e8a\u8a66\u9a13\u306e\u900f\u660e\u6027\u3001\u30ec\u30dd\u30fc\u30c8\u4f5c\u6210\u3001\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u30c7\u30fc\u30bf\u30c9\u30ea\u30d6\u30f3\u306a\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u306b\u3064\u3044\u3066
\n\uff082019\u5e7410\u670823\u65e5\uff09<\/p>\n

 <\/p>\n

Emerging leaders in generics: Successful strategies for growth<\/a>
\nAPI\u6d88\u8cbb\u304c\u5897\u52a0\u3057\u3066\u3044\u308b\u65b0\u3057\u3044\u5e02\u5834\u3092\u7279\u5b9a\u3059\u308b\u969b\u306b\u3001Newport (\u73fe Cortellis Generic Intelligence)\u304c\u3069\u306e\u3088\u3046\u306b\u30b5\u30dd\u30fc\u30c8\u3067\u304d\u308b\u304b\u3092\u3054\u7d39\u4ecb
\n\uff082019\u5e749\u670826\u65e5\uff09<\/p>\n

 <\/p>\n

Clinical trial transparency, reporting and real-time data driven compliance<\/a>
\n\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u958b\u793a\u3068\u30ea\u30bd\u30fc\u30b9\u3092\u7ba1\u7406\u3059\u308b\u305f\u3081\u306e\u30d9\u30b9\u30c8\u30d7\u30e9\u30af\u30c6\u30a3\u30b9
\n\uff082019\u5e748\u670814\u65e5\uff09<\/p>\n

 <\/p>\n

Oncology investment and partnering trends<\/a>
\n\u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u9818\u57df\u3067\u306e\u30c7\u30a3\u30fc\u30eb\u72b6\u6cc1\u306b\u3064\u3044\u3066\u77e5\u3063\u3066\u304a\u304f\u3079\u304d\u4e8b\u67c4\u306b\u3064\u3044\u3066
\n\uff082019\u5e745\u67089\u65e5\uff09<\/p>\n

 <\/p>\n

Analyzing rare disease trial designs over time: Exploring alternative trial designs<\/a>
\n\u5e0c\u5c11\u75be\u60a3\u9818\u57df\u3067\u306e\u81e8\u5e8a\u8a66\u9a13\u30c7\u30b6\u30a4\u30f3\u306b\u3064\u3044\u3066
\n\uff082018\u5e7410\u6708\uff09<\/p>\n

 <\/p>\n

Deals and portfolio review: Lessons for pharma from a challenging year<\/a>
\n2019\u5e74\u306b\u5411\u3051\u305f\u30c7\u30a3\u30fc\u30eb\u3068\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u306b\u95a2\u3059\u308b\u30a4\u30f3\u30b5\u30a4\u30c8
\n\uff082019\u5e741\u6708\uff09<\/p>\n

 <\/p>\n

Make better portfolio decisions through predictive analytics<\/a>
\n\u4e88\u6e2c\u5206\u6790\u306b\u3088\u308b\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u306e\u6539\u5584<\/p>\n

 <\/p>\n

Neuroscience investment, challenges and outlook<\/a>
\n\u795e\u7d4c\u79d1\u5b66\u5206\u91ce\u3067\u306e\u6295\u8cc7\u72b6\u6cc1\u306b\u3064\u3044\u3066
\n\uff082018\u5e746\u6708\uff09<\/p>\n

 <\/p>\n

Knowledge-based approaches to decreasing clinical attrition rates<\/a>
\n\u8a66\u9a13\u306e\u30a8\u30f3\u30c9\u30dd\u30a4\u30f3\u30c8\u306e\u6210\u529f\u306b\u95a2\u9023\u3059\u308b\u591a\u304f\u306e\u8981\u56e0\u306b\u3064\u3044\u3066<\/p>\n

 <\/p>\n

Identifying novel targets for NAFLD and NASH<\/a>
\nNAFLD\u304a\u3088\u3073NASH\u306e\u65b0\u898f\u30bf\u30fc\u30b2\u30c3\u30c8\u3092\u7279\u5b9a\u304a\u3088\u3073\u512a\u5148\u9806\u4f4d\u4ed8\u3051\u3059\u308b\u305f\u3081\u306e\u65b0\u3057\u3044\u30c4\u30fc\u30eb\u306b\u3064\u3044\u3066
\n\uff082018\u5e743\u6708\uff09<\/p>\n","protected":false},"excerpt":{"rendered":"

\u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u304c\u5b9f\u65bd\u3057\u3066\u3044\u308b\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u95a2\u4fc2\u306eWebinar\u30aa\u30f3\u30c7\u30de\u30f3\u30c9\u9332\u753b\u3092\u307e\u3068\u3081\u3066\u3054\u7d39\u4ecb\u3057\u3066\u304a\u308a\u307e\u3059\u3002 \u3054\u90fd\u5408\u306b\u5408\u308f\u305b\u3066\u3044\u3064\u3067\u3082\u8996\u8074\u53ef\u80fd\u306aWebinar\u30b7\u30ea\u30fc\u30ba\u3092\u662f\u975e\u3054\u53c2\u8003\u304f\u3060\u3055\u3044\u3002 \uff08\u6ce8\uff1a\u8b1b\u6f14\u8a00\u8a9e\u306f\u5168\u3066\u82f1\u8a9e\u3068\u306a\u308a\u307e\u3059\u3002\uff09   Digital innovation in clinical trials: Key questions answered \u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\uff1a\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u30c7\u30b8\u30bf\u30eb\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u304b\u3089\u629c\u7c8b\u3057\u305f\u30b7\u30e7\u30fc\u30c8\u30e0\u30fc\u30d3\u30fc (2020\u5e749\u670822\u65e5)   Digital innovation in clinical trials \u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\uff1a\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u30c7\u30b8\u30bf\u30eb\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3 (2020\u5e749\u670822\u65e5)   Deep-dives into generics and API manufacturing industry:…<\/p>\n","protected":false},"author":2,"featured_media":1697,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_links_to":"","_links_to_type":0,"footnotes":""},"categories":[1071,1073],"tags":[1075],"class_list":["post-1696","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","category-cortellis","tag-life-sciences"],"acf":[],"lang":"ja","translations":{"ja":1696},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/1696","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/comments?post=1696"}],"version-history":[{"count":0,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/1696\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media\/1697"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=1696"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/categories?post=1696"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/tags?post=1696"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}